Lung Cancer Clinical Trial
Patient-centered, Optimal Integration of Survivorship and Palliative Care
Summary
This study is being conducted to develop a supportive care model for patients with metastatic Non-small Cell Lung Cancer (NSCLC) to learn to cope with uncertainty and help them understand their prognosis and the goal of therapy, in order to live well with cancer.
Full Description
This research study involves an intervention consisting of four sessions with palliative care specialists who have been additionally trained to evaluate and address the specific psychosocial issues and health-promoting behaviors of patients with NSCLC.
The research study procedures include:
Four 60-minute visits with a trained palliative care clinician
Questionnaires and an exit interview
Chart Review
It is expected that about 15 participants currently receiving targeted therapy at Massachusetts General Hospital for lung cancer will take part in this research study
Eligibility Criteria
Inclusion Criteria:
Age 18 or older
MGH Cancer Center patient
Within 6 months of diagnosis of metastatic NSCLC with oncogenic driver mutation (EGFR, ALK, ROS1, RET)
Receiving targeted therapy
Ability to respond in English or Spanish
Exclusion Criteria:
Cognitive impairment or serious mental illness that limits ability to provide informed consent
Need for urgent palliative care or hospice referral
Pregnant women
Prisoners
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Boston Massachusetts, 02115, United States More Info
Principal Investigator
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.